Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
WSTWest Pharmaceutical Services
FinDog View：Neutral
| Metric | GILD | WST |
|---|
| Close | 147.68 | 362.01 |
| Market Cap | $183B | $23.9B |
| 1M | +6.31% | +4.44% |
| P/E (TTM) | — | 43.1 |
| Forward P/E | 25.3 | 36.0 |
| P/E 5-Yr Percentile | — | 49 |
| P/S | 6.0 | 7.3 |
| P/B | 15.3 | 8.2 |
| Dividend Yield | 3.98% | 0.33% |
| Latest Quarter Revenue | $7.8B | $872M |
| Revenue YoY | +10.2% | +13.8% |
| Gross Margin | 79.8% | 37.7% |
| Latest Quarter EPS | -8.45 | 2.15 |
| Avg Post-Earnings Move | ±3.8% | ±3.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | 1 / 1 |
| Shareholder Yield | 3.01% | 2.16% |
| 90-Day Net Insider Buying | −$15.4M | −$5.4M |
GILD · Revenue, Last 8 Quarters ($B)
WST · Revenue, Last 8 Quarters ($B)
